InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
4
T+90 hit rate
70%
T+90 mean return
-0.9%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Ali-Jackson Kamil, Directeur Juridique. Director active across 4 companies, notably Aclaris Therapeutics, Inc.. In total, 20 reports have been published. Split: 2 buys · 4 sells. Total volume traded: €571k. Activity tracked since 3 May 2021. The latest transaction was filed on 26 May 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations20 total
2,500 sharesCommon StockSEC:0000905148-26-003076:0
2,500 shares@ US$29.170.012% mcap100.0% of flowCommon StockSEC:0000905148-26-002724:0
5,750 shares0Common StockSEC:0000905148-26-002529:0
25,000 shares0Common StockSEC:0000905148-24-001651:0
25,000 shares0Common StockSEC:0001140361-23-034284:0
18,750 shares0Common StockSEC:0001140361-22-020303:0
3,875 sharesCommon StockSEC:0001209191-22-001712
3,875 sharesCommon StockSEC:0001209191-22-001712:0
7,500 shares0Common StockSEC:0001209191-21-066084
7,500 shares0Common StockSEC:0001209191-21-066084:0
11,764 shares@ US$8.5050.0% of flowCommon StockSEC:0001140361-21-021497
Ideal exit: 12 Mar 2022 (T+270)
11,764 shares@ US$8.500.20% mcap50.0% of flowCommon StockSEC:0001140361-21-021497:0
Ideal exit: 12 Mar 2022 (T+270)
9,492 shares@ US$21.957523.2% of flowCommon StockSEC:0001209191-21-038442
9,492 shares@ US$21.95750.027% mcap23.2% of flowCommon StockSEC:0001209191-21-038442:0
33,189 sharesCommon StockSEC:0001209191-21-037482
33,189 sharesCommon StockSEC:0001209191-21-037482:0
15,000 shares@ US$10.660.021% mcap17.9% of flowCommon StockSEC:0001209191-21-031038:0
15,000 shares@ US$10.6617.9% of flowCommon StockSEC:0001209191-21-031038
15,000 shares@ US$10.660.021% mcap17.9% of flowCommon StockSEC:0001209191-21-030491:0
15,000 sharesCommon StockSEC:0001209191-21-030491
20 of 20 declarations
About Ali-Jackson Kamil
Ali-Jackson Kamil is the Legal Director at Aclaris Therapeutics, Inc. He oversees the legal affairs of the company.
